Not Yet Recruiting NA INTERVENTIONAL 4-arm NCT05285332

Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy (CS)

Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapywhich Patients Will Benefit From Surgery

Sponsor: Changhai Hospital

Conditions Breast Neoplasms Metastatic Breast Cancer Survival Treatment

Interventions Systemic therapy surgical treatment 1 surgical treatment 2

Updated 5 times since 2022 Last updated: Jul 17, 2022 Started: Aug 1, 2022 Primary completion: Dec 31, 2030 Completion: May 1, 2031

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Neoplasms and Metastatic Breast Cancer, this trial is actively recruiting participants. The trial is conducted by Changhai Hospital and has accumulated 5 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Not Yet Recruiting NA
May 2022 — Sep 2022 [monthly]

Not Yet Recruiting NA
Apr 2022 — May 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changhai Hospital

Data source: Changhai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.